Evofem Biosciences, Inc. (EVFM)
OTCMKTS: EVFM · Delayed Price · USD
0.0149
+0.0021 (16.04%)
Apr 24, 2024, 3:58 PM EDT - Market closed
Evofem Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 3 | 4 | 49 | 162 | 248 | 92 | 23 | 15 | 19 | 102 | 159 | Upgrade
|
| Market Cap Growth | - | -92.43% | -69.59% | -34.79% | 170.49% | 300.27% | 48.40% | -18.83% | -81.39% | -35.76% | 0% | Upgrade
|
| Enterprise Value | 45 | 72 | 157 | 199 | 233 | 94 | 20 | 4 | -9 | 36 | 155 | Upgrade
|
| PE Ratio | 0.00 | -0.05 | -0.24 | -1.14 | -3.10 | -0.73 | -2.29 | -1.19 | -0.44 | -9.45 | -10.60 | Upgrade
|
| PS Ratio | 0.24 | 0.22 | 5.97 | 362.89 | - | - | - | - | - | - | - | Upgrade
|
| PB Ratio | -0.01 | -0.05 | 10.38 | 120.15 | 15.87 | -3.93 | 8.47 | 1.30 | 0.80 | 1.57 | 199.63 | Upgrade
|
| P/FCF Ratio | -0.04 | -0.05 | -0.33 | -1.51 | -4.49 | -1.62 | -2.80 | -0.95 | -0.50 | -10.66 | -12.31 | Upgrade
|
| P/OCF Ratio | -0.04 | -0.05 | -0.34 | -1.54 | -4.50 | -1.62 | -2.80 | -0.95 | -0.50 | -10.68 | -12.33 | Upgrade
|
| EV/Sales Ratio | 3.29 | 4.28 | 19.06 | 445.96 | - | - | - | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | -0.41 | -0.77 | -1.18 | -2.97 | -5.18 | -3.19 | -1.96 | -0.33 | 0.21 | -3.76 | -10.77 | Upgrade
|
| EV/EBIT Ratio | -0.41 | -0.76 | -1.17 | -2.96 | -5.15 | -3.16 | -1.95 | -0.33 | 0.21 | -3.75 | -10.71 | Upgrade
|
| EV/FCF Ratio | -2.74 | -1.02 | -1.05 | -1.86 | -4.21 | -1.67 | -2.38 | -0.24 | 0.23 | -3.76 | -11.99 | Upgrade
|
| Debt / Equity Ratio | -0.76 | -0.99 | 24.41 | 63.80 | 0.01 | -0.17 | 0 | 0 | 0.42 | 0.15 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | -0.40 | -0.76 | -0.87 | -1.29 | 0.00 | -0.14 | - | - | -0.24 | -1.02 | -0.01 | Upgrade
|
| Debt / FCF Ratio | -2.68 | -1.01 | -0.77 | -0.80 | 0.00 | -0.07 | - | - | -0.26 | -1.02 | -0.02 | Upgrade
|
| Quick Ratio | 0.10 | 0.04 | 0.10 | 0.65 | 1.93 | 0.06 | 2.42 | 12.72 | 4.15 | 39.77 | 2.86 | Upgrade
|
| Current Ratio | 0.17 | 0.14 | 0.14 | 1.26 | 2.09 | 0.09 | 2.85 | 13.86 | 4.37 | 40.26 | 2.95 | Upgrade
|
| Asset Turnover | 0.79 | 0.67 | 0.43 | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Coverage | 0 | 4.68 | 0 | 0 | 0 | 0 | 0 | -11.63 | -37.08 | -25.58 | -253.88 | Upgrade
|
| Return on Equity (ROE) | -85.70% | 106.82% | -4328.95% | -10564.88% | -511.85% | 538.24% | -369.20% | -109.27% | -181.28% | -16.58% | -1883.41% | Upgrade
|
| Return on Assets (ROA) | 350.98% | -304.80% | -1066.65% | -129.41% | -282.85% | -3134.96% | -242.63% | -101.58% | -107.59% | -14.07% | -331.46% | Upgrade
|
| Return on Capital (ROIC) | 198.85% | 12518.45% | -138.51% | -118.72% | -333.11% | 401.33% | -371.10% | -101.07% | -124.52% | -12.79% | -1435.97% | Upgrade
|
| Earnings Yield | 1453.06% | -2057.42% | -416.87% | -87.93% | -32.24% | -137.00% | -43.59% | -84.28% | -226.77% | -10.58% | -9.43% | Upgrade
|
| FCF Yield | -477.59% | -1897.89% | -303.94% | -66.16% | -22.26% | -61.58% | -35.77% | -105.23% | -200.40% | -9.38% | -8.12% | Upgrade
|
| Dividend Yield | 0.00% | 0.00% | 0.00% | 29.12% | 30.38% | 0.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Payout Ratio | 0.00% | 0.00% | 0.00% | -33.12% | -94.21% | -0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Buyback Yield / Dilution | 4.63% | -567.43% | -94.93% | -66.94% | -83.69% | -1017.70% | 14.76% | -0.74% | -0.16% | -3.05% | - | Upgrade
|
| Total Shareholder Return | 4.63% | -567.43% | -94.93% | -37.82% | -53.31% | -1017.53% | 14.76% | -0.74% | -0.16% | -3.05% | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.